Solving safety data complexity is not an AI quick-fix - Qinecsa
Solving safety data complexity is not an AI quick-fix
- Articles, Resources
- February 23, 2026
European Pharmaceutical Manufacturer spotlights Daniel O’Keeffe of Qinecsa Solutions in a recent article examining whether patient outcomes are being compromised by fragmented and inconsistent safety data. Daniel highlights the critical need to improve how adverse event data is captured at source, arguing that AI’s greatest value lies in enabling better data collection rather than fixing poor-quality inputs later. He also explores how stronger regulatory direction and more structured reporting approaches could help the industry unlock clearer safety insights and ultimately drive better patient outcomes.
Recent Articles
The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?
- July 28, 2026
Embracing quantitative signal detection methods as a smaller MAH
- June 25, 2026
Real-Time Safety Signals Drive Continuous PV Insight
- May 27, 2026
From Complaint Handling to Active Surveillance
- May 5, 2026
Continuous Safety Surveillance for Medical Devices
- May 5, 2026
Are patient outcomes getting lost in safety data complexity?
- May 5, 2026
Previous: Future Ready Pharmacovigilance: When and Why to Outsource
Next: Could GLP-1 obesity drugs break pharma’s safety infrastructure?